All Relations between dopaminergic and Substantia nigra

Publication Sentence Publish Date Extraction Date Species
Caleb A H Jones, Benjamin P Brown, Daniel C Schultz, Julie Engers, Valerie M Kramlinger, Jens Meiler, Craig W Lindsle. Computer-Aided Design and Biological Evaluation of Diazaspirocyclic D ACS chemical neuroscience. 2024-06-08. PMID:38847395. computer-aided design and biological evaluation of diazaspirocyclic d parkinson's disease (pd) is a neurodegenerative disorder characterized by the progressive loss of dopaminergic neurons in the substantia nigra, resulting in motor dysfunction. 2024-06-08 2024-06-10 Not clear
Yichen Zhao, Weiwei Shen, Minjie Zhang, Min Guo, Yunxiao Dou, Sida Han, Jintai Yu, Mei Cui, Yanxin Zha. DDAH-1 maintains endoplasmic reticulum-mitochondria contacts and protects dopaminergic neurons in Parkinson's disease. Cell death & disease. vol 15. issue 6. 2024-06-07. PMID:38849335. the loss of dopaminergic neurons in the substantia nigra is a hallmark of pathology in parkinson's disease (pd). 2024-06-07 2024-06-10 rat
Ozge Akyazı, Dılara Korkmaz, Sule Coskun Cevhe. Experimental Parkinson Models and Green Chemistry Approach. Behavioural brain research. 2024-06-06. PMID:38844056. the disease primarily impairs the functional capacity of the person with cardinal findings such as tremor, bradykinesia, etc., as a result of the loss of dopaminergic neurons in the substantia nigra. 2024-06-06 2024-06-10 Not clear
Penelope A Young, Olivia Waller, Katherine Ball, Chad C Williams, Raad Nashm. Phasic stimulation of dopaminergic neurons of the lateral substantia nigra increases open field exploratory behaviour and reduces habituation over time. Neuroscience. 2024-06-05. PMID:38838978. phasic stimulation of dopaminergic neurons of the lateral substantia nigra increases open field exploratory behaviour and reduces habituation over time. 2024-06-05 2024-06-08 mouse
Riptee Thakur, Chandana Nagaraj, Raman Kumar Joshi, Jitender Saini, Ravi Yadav, Pardeep Kuma. Standardization and Clinical Use of a Single-vial Formulation of Technetium-99m-Trodat Using Autoclave Method. Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India. vol 39. issue 1. 2024-06-01. PMID:38817725. parkinson's disease (pd) is characterized by the degeneration of dopaminergic neurons in the substantia nigra. 2024-06-01 2024-06-02 Not clear
Mohammad Sophiabadi, Nafiseh Rastgoo, Hashem Haghdoost-Yazd. Retraction Note: Dopaminergic Neuronal Death in Substantia Nigra Associates with Serum Levels of Total Bilirubin, Selenium, and Zinc: Evidences from 6-Hydroxydopamine Animal Model of Parkinson's Disease. Biological trace element research. 2024-05-29. PMID:38809398. retraction note: dopaminergic neuronal death in substantia nigra associates with serum levels of total bilirubin, selenium, and zinc: evidences from 6-hydroxydopamine animal model of parkinson's disease. 2024-05-29 2024-06-03 Not clear
Brian H Kopell, Deepak A Kaji, Lora E Liharska, Eric Vornholt, Alissa Valentine, Anina Lund, Alice Hashemi, Ryan C Thompson, Terry Lohrenz, Jessica S Johnson, Nicole Bussola, Esther Cheng, You Jeong Park, Punit Shah, Weiping Ma, Richard Searfoss, Salman Qasim, Gregory M Miller, Nischal Mahaveer Chand, Alisha Aristel, Jack Humphrey, Lillian Wilkins, Kimia Ziafat, Hannah Silk, Lisa M Linares, Brendan Sullivan, Claudia Feng, Seth R Batten, Dan Bang, Leonardo S Barbosa, Thomas Twomey, Jason P White, Marina Vannucci, Beniamino Hadj-Amar, Vanessa Cohen, Prashant Kota, Emily Moya, Marysia-Kolbe Rieder, Martijn Figee, Girish N Nadkarni, Michael S Breen, Kenneth T Kishida, Joseph Scarpa, Douglas M Ruderfer, Niven R Narain, Pei Wang, Michael A Kiebish, Eric E Schadt, Ignacio Saez, P Read Montague, Noam D Beckmann, Alexander W Charne. Multiomic foundations of human prefrontal cortex tissue function. medRxiv : the preprint server for health sciences. 2024-05-27. PMID:38798344. rna transcript expression within multiple pfc cell types was associated with fluctuations of dopaminergic, serotonergic, and/or noradrenergic neurotransmission in the substantia nigra measured while participants played a computer game that engaged higher-order brain functions. 2024-05-27 2024-05-31 human
Gayatri Reddy Aaluri, Yashmit Choudhary, Subodh Kuma. Mitochondria-Associated MicroRNAs and Parkinson's Disease. Neuroscience insights. vol 19. 2024-05-27. PMID:38800624. parkinson's disease (pd) occurs as a result of the progressive loss of dopaminergic neurons within the substantia nigra causing motor and non-motor symptoms and has become more prevalent within the last several decades. 2024-05-27 2024-05-31 Not clear
Manuel Belli, Mario Cristina, Valeria Calabrese, Marta Russo, Marisa Granato, Matteo Antonio Russo, Luigi Sanson. Ultrastructural Changes of Neuroendocrine Pheochromocytoma Cell Line PC-12 Exposed In Vitro to Rotenone. Brain sciences. vol 14. issue 5. 2024-05-25. PMID:38790454. this includes a selective death of dopaminergic neurons in the substantia nigra. 2024-05-25 2024-05-27 Not clear
Anand Thirupathi, Luis Felipe Marqueze, Tiago F Outeiro, Zsolt Radak, Ricardo A Pinh. Physical Exercise-Induced Activation of NRF2 and BDNF as a Promising Strategy for Ferroptosis Regulation in Parkinson's Disease. Neurochemical research. 2024-05-23. PMID:38782838. parkinson's disease (pd) is a progressive neurodegenerative disorder characterized by the loss of dopaminergic neurons in the substantia nigra. 2024-05-23 2024-05-27 Not clear
Bruna da Silva Oliveira, Eliana Cristina de Brito Toscano, Larissa Katharina Sabino Abreu, Heliana de Barros Fernandes, Renan Florindo Amorim, Rodrigo Novaes Ferreira, Caroline Amaral Machado, Brener Cunha Carvalho, Maria Carolina Machado da Silva, Antônio Carlos Pinheiro de Oliveira, Milene Alvarenga Rachid, Natália Pessoa Rocha, Antônio Lúcio Teixeira, Elizabeth Ribeiro da Silva, Aline Silva de Mirand. Nigrostriatal Inflammation Is Associated with Nonmotor Symptoms in an Experimental Model of Prodromal Parkinson's Disease. Neuroscience. vol 549. 2024-05-22. PMID:38750924. intranasal mptp infusion was able to cause the loss of dopaminergic neurons in the substantia nigra (sn). 2024-05-22 2024-05-27 mouse
Lene Clausen, Justyna Okarmus, Vasileios Voutsinos, Morten Meyer, Kresten Lindorff-Larsen, Rasmus Hartmann-Peterse. PRKN-linked familial Parkinson's disease: cellular and molecular mechanisms of disease-linked variants. Cellular and molecular life sciences : CMLS. vol 81. issue 1. 2024-05-20. PMID:38767677. parkinson's disease (pd) is a common and incurable neurodegenerative disorder that arises from the loss of dopaminergic neurons in the substantia nigra and is mainly characterized by progressive loss of motor function. 2024-05-20 2024-05-27 human
Naif H Ali, Hayder M Al-Kuraishy, Ali I Al-Gareeb, Athanasios Alexiou, Marios Papadakis, Ali Abdullah AlAseeri, Mubarak Alruwaili, Hebatallah M Saad, Gaber El-Saber Batih. BDNF/TrkB activators in Parkinson's disease: A new therapeutic strategy. Journal of cellular and molecular medicine. vol 28. issue 10. 2024-05-16. PMID:38752280. parkinson's disease (pd) is a neurodegenerative disorder of the brain and is manifested by motor and non-motor symptoms because of degenerative changes in dopaminergic neurons of the substantia nigra. 2024-05-16 2024-05-27 Not clear
Naif H Ali, Hayder M Al-Kuraishy, Ali I Al-Gareeb, Athanasios Alexiou, Marios Papadakis, Ali Abdullah AlAseeri, Mubarak Alruwaili, Hebatallah M Saad, Gaber El-Saber Batih. BDNF/TrkB activators in Parkinson's disease: A new therapeutic strategy. Journal of cellular and molecular medicine. vol 28. issue 10. 2024-05-16. PMID:38752280. bdnf promotes the survival of dopaminergic neurons in the substantia nigra and enhances the functional activity of striatal neurons. 2024-05-16 2024-05-27 Not clear
Naif H Ali, Hayder M Al-Kuraishy, Ali I Al-Gareeb, Athanasios Alexiou, Marios Papadakis, Ali Abdullah AlAseeri, Mubarak Alruwaili, Hebatallah M Saad, Gaber El-Saber Batih. BDNF/TrkB activators in Parkinson's disease: A new therapeutic strategy. Journal of cellular and molecular medicine. vol 28. issue 10. 2024-05-16. PMID:38752280. deficiency of the trkb receptor triggers degeneration of dopaminergic neurons and accumulation of α-syn in the substantia nigra. 2024-05-16 2024-05-27 Not clear
Ping Fang, Lewis W Yu, Hannah Espey, Gulistan Agirman, Sabeen A Kazmi, Kai Li, Yongning Deng, Jamie Lee, Haley Hrncir, Arlene Romero-Lopez, Arthur P Arnold, Elaine Y Hsia. Sex-dependent interactions between prodromal intestinal inflammation and LRRK2 G2019S in mice promote endophenotypes of Parkinson's disease. Communications biology. vol 7. issue 1. 2024-05-15. PMID:38750146. chronic intestinal damage in genetically predisposed male mice promotes α-synuclein aggregation in the substantia nigra, loss of dopaminergic neurons and motor impairment. 2024-05-15 2024-05-27 mouse
Lina Ding, Long Wang, Jiaxin Yang, Cuicui Jiang, Xifeng Sun, Huite Huang, Xiuyuan Zhan, Feilong Liu, Qunlin Zhan. (+)-Borneol Protects Dopaminergic Neuronal Loss in Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Induced Parkinson's Disease Mice: A Study of Dopamine Level using In Vivo Brain Microdialysis. ACS chemical neuroscience. 2024-05-15. PMID:38747405. it is worth noting that the enhanced level of da by (+)-borneol was enabled by the reduction in loss of tyrosine hydroxylase-immunoreactive dopaminergic neurons in the substantia nigra and striatum and promotion of reserpine- or nomifensine-induced da release in pd mice. 2024-05-15 2024-05-27 mouse
Seyed Amir Farzam, Shahram Darabi, Hashem Haghdoost-Yazdi, Yasamin Zaferan. Dexmedetomidine, an alpha-2 adrenoceptors agonist, provides a neuroprotective effect for dopaminergic neurons in the substantia nigra and attenuates glucose imbalance in the 6-hydroxydopamine animal model of Parkinson's disease. Neurological research. 2024-05-13. PMID:38740025. dexmedetomidine, an alpha-2 adrenoceptors agonist, provides a neuroprotective effect for dopaminergic neurons in the substantia nigra and attenuates glucose imbalance in the 6-hydroxydopamine animal model of parkinson's disease. 2024-05-13 2024-05-27 rat
Seyed Amir Farzam, Shahram Darabi, Hashem Haghdoost-Yazdi, Yasamin Zaferan. Dexmedetomidine, an alpha-2 adrenoceptors agonist, provides a neuroprotective effect for dopaminergic neurons in the substantia nigra and attenuates glucose imbalance in the 6-hydroxydopamine animal model of Parkinson's disease. Neurological research. 2024-05-13. PMID:38740025. here, we evaluated the effect of prolonged treatment with low doses of dex on the survival rate of dopaminergic (daergic) neurons in the substantia nigra and also serum glucose levels in 6-hydroxydopamine (6-ohda) - induced parkinson's disease (pd) in the rat. 2024-05-13 2024-05-27 rat
Riya Thapa, Ehssan Moglad, Muhammad Afzal, Gaurav Gupta, Asif Ahmad Bhat, Waleed Hassan Almalki, Imran Kazmi, Sami I Alzarea, Kumud Pant, Haider Ali, Keshav Raj Paudel, Harish Dureja, Thakur Gurjeet Singh, Sachin Kumar Singh, Kamal Du. ncRNAs and Their Impact on Dopaminergic Neurons: Autophagy Pathways in Parkinson's Disease. Ageing research reviews. 2024-05-11. PMID:38734148. parkinson's disease (pd) is a complex neurological illness that causes severe motor and non-motor symptoms due to a gradual loss of dopaminergic neurons in the substantia nigra. 2024-05-11 2024-05-27 Not clear